4-amino-1-tert-butyl-3-(m-(2',6'-dichloro)benzyloxyphenyl)pyrazolo<3,4-d>pyrimidine | 221243-97-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-amino-1-tert-butyl-3-(m-(2',6'-dichloro)benzyloxyphenyl)pyrazolo<3,4-d>pyrimidine
• 英文别名: 1-tert-butyl-3-(3-(2,6-dichlorobenzyloxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine；4-amino-1-tert-butyl-3-(m-(2',6'-dichloro)benzyloxyphenyl)pyrazolo[3,4-d]pyrimidine；1-tert-butyl-3-[3-[(2,6-dichlorophenyl)methoxy]phenyl]pyrazolo[3,4-d]pyrimidin-4-amine
• CAS: 221243-97-6
• 化学式: C₂₂H₂₁Cl₂N₅O
• 分子量: 442.348
• InChiKey: BMSUFHWQIJKJFR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  78.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-amino-1-tert-butyl-3-(m-(2',6'-dichloro)benzyloxyphenyl)pyrazolo<3,4-d>pyrimidine 在 乙腈 、 水 、 三氟乙酸 作用下， 以 甲酸 、 盐酸 为溶剂， 反应 0.5h， 生成 3-(3-(2,6-dichlorobenzyloxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  参考文献：
  名称：

  Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists

  摘要：

  本发明提供了一种新颖的化合物，可用作脂质激酶（如PI3激酶，蛋白酪氨酸激酶和/或蛋白丝氨酸/苏氨酸激酶，如mTOR）的拮抗剂。本发明还提供了使用这些化合物治疗各种疾病的方法。这些化合物包括具有以下式的化合物：其中R1，R2和R36如本文所定义。

  公开号：

  US07585868B2
• 作为产物：
  描述：

  2-{[3-(2,6-Dichloro-benzyloxy)-phenyl]-methoxy-methylene}-malononitrile 在 三乙胺 作用下， 以 乙醇 为溶剂， 反应 13.0h， 生成 4-amino-1-tert-butyl-3-(m-(2',6'-dichloro)benzyloxyphenyl)pyrazolo<3,4-d>pyrimidine
  参考文献：
  名称：

  Generation of Monospecific Nanomolar Tyrosine Kinase Inhibitors via a Chemical Genetic Approach

  摘要：

  Selective protein kinase inhibitors are highly sought after as tools for studying cellular signal transduction cascades, yet few have been discovered due to the highly conserved fold of kinase catalytic domains. Through a combination of small molecule synthesis and protein mutagenesis, a highly potent (IC50 = 1.5 nM) and uniquely specific inhibitor (4-amino-1-tert-butyl-3-(1'-naphthyl)pyrazolo[3,4-d]pyrimidine) of a rationally engineered v-Src tyrosine kinase (Ile338Gly v-Src) has been identified. Both the potency and specificity of this compound surpass those of any known Src family tyrosine kinase inhibitors. The molecule strongly inhibits the engineered v-Src in whole cells but does not inhibit tyrosine phosphorylation in cells that express only wild-type tyrosine kinases. In addition, the inhibitor selectively disrupts transformation in cells that express the target v-Src. The structural degeneracy of kinase active sites should allow the same complementary inhibitor/protein design strategy to be widely applicable across this entire enzyme superfamily.

  DOI：

  10.1021/ja983267v

文献信息

• Kinase antagonists
  申请人：Knight A. Zachary

  公开号：US20070293516A1

  公开（公告）日：2007-12-20

  The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tryosine kinase, PI3Kinase and mTOR, or PI3Kinase, mTOR and tryosine kinase.

  本发明提供了一种新型化合物，它们是 PI3 激酶、PI3 激酶和酪氨酸激酶、PI3 激酶和 mTOR，或者 PI3 激酶、mTOR 和酪氨酸激酶的拮抗剂。
• Novel chain-breaking antioxidants
  申请人：——

  公开号：US20020143025A1

  公开（公告）日：2002-10-03

  Compounds, preferably 5-pyrimidinol and 3-pyridinol derivatives, that act as effective chain breaking antioxidants of both the lipid and water-soluble variety (analogous to the natural Vitamins E and C), many of which are more reactive toward peroxyl radicals than the most potent form of Vitamin E. These compounds may exhibit many chemopreventive effects associated with conditions in which free radical-mediated cellular damage or disruption is implicated and Vitamins E and C are shown to have protective effects. Additionally, these compounds should be excellent oxidation inhibitors as additives to fuels, lubricants, rubber, polymers, chemicals, solvents and foodstuffs.

  化合物，最好是5-嘧啶醇和3-吡啶醇衍生物，作为有效的链断裂抗氧化剂，既可以溶解于脂质又可以溶解于水（类似于天然维生素E和C），其中许多对过氧自由基的反应性比最有效的维生素E形式更高。这些化合物可能展现出许多与自由基介导的细胞损伤或破坏相关的化学预防效应，而维生素E和C已经显示出具有保护作用。此外，这些化合物应该作为添加剂，对燃料、润滑剂、橡胶、聚合物、化学品、溶剂和食品等具有出色的氧化抑制作用。
• KINASE ANTAGONISTS
  申请人：KNIGHT ZACHARY A.

  公开号：US20100009963A1

  公开（公告）日：2010-01-14

  The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.

  本发明提供了一些新型化合物，它们是PI3激酶、PI3激酶和酪氨酸激酶、PI3激酶和mTOR、或PI3激酶、mTOR和酪氨酸激酶的拮抗剂。
• NOVEL CHAIN-BREAKING ANTIOXIDANTS
  申请人：Pratt Derek A.

  公开号：US20100041683A1

  公开（公告）日：2010-02-18

  Compounds, preferably 5-pyrimidinol and 3-pyridinol derivatives, that act as effective chain breaking antioxidants of both the lipid and water-soluble variety (analogous to the natural Vitamins E and C), many of which are more reactive toward peroxyl radicals than the most potent form of Vitamin E. These compounds may exhibit many chemopreventive effects associated with conditions in which free radical-mediated cellular damage or disruption is implicated and Vitamins E and C are shown to have protective effects. Additionally, these compounds should be excellent oxidation inhibitors as additives to fuels, lubricants, rubber, polymers, chemicals, solvents and foodstuffs.

  这段话的意思是：化合物，最好是5-嘧啶醇和3-吡啶醇衍生物，可作为有效的链断裂抗氧化剂，既能作用于脂质又能作用于水溶性类似于天然维生素E和C，其中许多化合物对过氧自由基的反应性比维生素E最强的形式还要高。这些化合物可能表现出许多与自由基介导的细胞损伤或破坏有关的化学预防效应，并且已经证明维生素E和C具有保护作用。此外，这些化合物应该是优秀的氧化抑制剂，可作为添加剂添加到燃料、润滑剂、橡胶、聚合物、化学品、溶剂和食品中。
• Kinase Antagonists
  申请人：Knight Zachary A.

  公开号：US20110301144A1

  公开（公告）日：2011-12-08

  The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.

  本发明提供了一种新型化合物，它们是PI3激酶、PI3激酶和酪氨酸激酶、PI3激酶和mTOR或PI33激酶、mTOR和酪氨酸激酶的拮抗剂。